Global RNAi for Therapeutic Market Research Report 2011-2023

2017-07-14 / 2320.00 / Pharma & Healthcare / 77 Pages

Description

Summary
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market will reach xxx Million USD in 2017. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
siRNA
miRNA
shRNA
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Alnylam Pharmaceuticals
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
miRagen Therapeutics
Gradalis
Sirnaomics
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Cancer
Cardiovascular
HBV
Other
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

Table of Content

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.2 Market Segment
1.2.1 by Type
1.2.1.1 siRNA
1.2.1.2 miRNA
1.2.1.3 shRNA
1.2.2 by Application
1.2.2.1 Cancer
1.2.2.2 Cardiovascular
1.2.2.3 HBV
1.2.2.4 Other
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 siRNA Market, 2011-2016
4.1.2 miRNA Market, 2011-2016
4.1.3 shRNA Market, 2011-2016
4.2 Market Forecast
4.2.1 siRNA Market Forecast, 2017-2022
4.2.2 miRNA Market Forecast, 2017-2022
4.2.3 shRNA Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Cancer Market, 2011-2016
5.1.2 Cardiovascular Market, 2011-2016
5.1.3 HBV Market, 2011-2016
5.1.4 Other Market, 2011-2016
5.2 Market Forecast
5.2.1 Cancer Market Forecast, 2017-2022
5.2.2 Cardiovascular Market Forecast, 2017-2022
5.2.3 HBV Market Forecast, 2017-2022
5.2.4 Other Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Alnylam Pharmaceuticals
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Arrowhead
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Dicerna Pharmaceuticals
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Mirna Therapeutics
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Quark Pharmaceuticals
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 RXi Pharmaceuticals
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 miRagen Therapeutics
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Gradalis
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.9 Sirnaomics
8.9.1 Profile
8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)
9 Conclusion


Table of Figures

Figure RNAi for Therapeutic Picture
Figure Industry Chain Structure of RNAi for Therapeutic
Figure SWOT of RNAi for Therapeutic
Figure siRNA Market Size and Growth, 2011-2016 (USD Million)
Figure siRNA Market Size and Growth, 2011-2016 (in Volume)
Figure miRNA Market Size and Growth, 2011-2016 (USD Million)
Figure miRNA Market Size and Growth, 2011-2016 (in Volume)
Figure shRNA Market Size and Growth, 2011-2016 (USD Million)
Figure shRNA Market Size and Growth, 2011-2016 (in Volume)
Figure siRNA Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure siRNA Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure miRNA Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure miRNA Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure shRNA Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure shRNA Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Cancer Market Size and Growth, 2011-2016 (USD Million)
Figure Cancer Market Size and Growth, 2011-2016 (in Volume)
Figure Cardiovascular Market Size and Growth, 2011-2016 (USD Million)
Figure Cardiovascular Market Size and Growth, 2011-2016 (in Volume)
Figure HBV Market Size and Growth, 2011-2016 (USD Million)
Figure HBV Market Size and Growth, 2011-2016 (in Volume)
Figure Other Market Size and Growth, 2011-2016 (USD Million)
Figure Other Market Size and Growth, 2011-2016 (in Volume)
Figure Cancer Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Cancer Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Cardiovascular Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Cardiovascular Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure HBV Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure HBV Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Other Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Other Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure RNAi for Therapeutic Market Concentration by Region
Figure Marketing Channels Overview


List Of Table

Table Product Specifications of RNAi for Therapeutic
Table Products Segment of RNAi for Therapeutic
Table siRNA Overview
Table miRNA Overview
Table shRNA Overview
Table Global RNAi for Therapeutic Market by Type, 2011-2022 (USD Million)
Table Application Segment of RNAi for Therapeutic
Table Cancer Overview
Table Cardiovascular Overview
Table HBV Overview
Table Other Overview
Table Global RNAi for Therapeutic Market by Application, 2011-2022 (USD Million)
Table Global RNAi for Therapeutic Market by Region, 2011-2022 (USD Million)
Table Cost of RNAi for Therapeutic
Table Market Dynamics
Table Policy of RNAi for Therapeutic
Table GDP of Major Countries
Table siRNA CAGR by Revenue and Volume, 2011-2016
Table miRNA CAGR by Revenue and Volume, 2011-2016
Table shRNA CAGR by Revenue and Volume, 2011-2016
Table siRNA CAGR by Revenue and Volume, 2012-2022
Table miRNA CAGR by Revenue and Volume, 2012-2022
Table shRNA CAGR by Revenue and Volume, 2012-2022
Table Cancer CAGR by Revenue and Volume, 2011-2016
Table Cardiovascular CAGR by Revenue and Volume, 2011-2016
Table HBV CAGR by Revenue and Volume, 2011-2016
Table Other CAGR by Revenue and Volume, 2011-2016
Table Cancer CAGR by Revenue and Volume, 2017-2022
Table Cardiovascular CAGR by Revenue and Volume, 2017-2022
Table HBV CAGR by Revenue and Volume, 2017-2022
Table Other CAGR by Revenue and Volume, 2017-2022
Table Global RNAi for Therapeutic Market by Vendors, 2011-2016 (USD Million)
Table Global RNAi for Therapeutic Market by Vendors, 2011-2016 (in Volume)
Table Global RNAi for Therapeutic Market Share by Vendors, 2011-2016 (USD Million)
Table Global RNAi for Therapeutic Market Share by Vendors, 2011-2016 (in Volume)
Table Price Factors List
Table Alnylam Pharmaceuticals Profile List
Table RNAi for Therapeutic Operating Data of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Arrowhead Profile List
Table RNAi for Therapeutic Operating Data of Arrowhead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dicerna Pharmaceuticals Profile List
Table RNAi for Therapeutic Operating Data of Dicerna Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mirna Therapeutics Profile List
Table RNAi for Therapeutic Operating Data of Mirna Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Quark Pharmaceuticals Profile List
Table RNAi for Therapeutic Operating Data of Quark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table RXi Pharmaceuticals Profile List
Table RNAi for Therapeutic Operating Data of RXi Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table miRagen Therapeutics Profile List
Table RNAi for Therapeutic Operating Data of miRagen Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gradalis Profile List
Table RNAi for Therapeutic Operating Data of Gradalis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sirnaomics Profile List
Table RNAi for Therapeutic Operating Data of Sirnaomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Part of Source List
Table Methodology of HeyReport Overview

Request Sample

captcha
Can't read the image? click here to refresh
* mark fields are compulsory